
• Reported GAAP EPS of $3.37 up 32.68% YoY • Reported revenue of $3.54B up 5.75% YoY • Labcorp raised full-year 2026 enterprise revenue guidance to 5.0% to 6.1% and adjusted EPS guidance to a range of $17.70 to $18.35, reflecting an increase of 13 cents at the midpoint.
Bullish
Labcorp achieved robust Q1 2026 revenue and Adjusted EPS growth, driven by strategic collaborations and investments in advanced technologies like AI and genomic testing.
Bearish
Labcorp faced increased total debt for pre-funding and a cash outflow from rising accounts receivable. The Diagnostics segment also experienced an impact from adverse weather conditions.